OTCMKTS:OWCP

OWC Pharmaceutical Research Competitors

$0.01
0.00 (-1.71 %)
(As of 04/9/2021 03:57 PM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.01
MA: $0.01
$0.02
52-Week Range
$0.01
Now: $0.01
$0.04
Volume502,495 shs
Average Volume6.86 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

OWC Pharmaceutical Research (OTCMKTS:OWCP) Vs. IIPR, GRWG, XXII, KSHB, NSAV, and TRTC

Should you be buying OWCP stock or one of its competitors? Companies in the sub-industry of "cannabis" are considered alternatives and competitors to OWC Pharmaceutical Research, including Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), NSAV (NSAV), and Terra Tech (TRTC).

OWC Pharmaceutical Research (OTCMKTS:OWCP) and Innovative Industrial Properties (NYSE:IIPR) are both miscellaneous companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Profitability

This table compares OWC Pharmaceutical Research and Innovative Industrial Properties' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
OWC Pharmaceutical ResearchN/AN/AN/A
Innovative Industrial Properties55.71%6.05%4.82%

Insider & Institutional Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for OWC Pharmaceutical Research and Innovative Industrial Properties, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
OWC Pharmaceutical Research0000N/A
Innovative Industrial Properties02502.71

Innovative Industrial Properties has a consensus price target of $192.4286, suggesting a potential upside of 1.82%. Given Innovative Industrial Properties' higher probable upside, analysts clearly believe Innovative Industrial Properties is more favorable than OWC Pharmaceutical Research.

Valuation & Earnings

This table compares OWC Pharmaceutical Research and Innovative Industrial Properties' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OWC Pharmaceutical ResearchN/AN/AN/AN/AN/A
Innovative Industrial Properties$44.67 million101.23$23.48 million$3.2757.80

Innovative Industrial Properties has higher revenue and earnings than OWC Pharmaceutical Research.

Summary

Innovative Industrial Properties beats OWC Pharmaceutical Research on 8 of the 8 factors compared between the two stocks.

OWC Pharmaceutical Research (OTCMKTS:OWCP) and GrowGeneration (NASDAQ:GRWG) are both miscellaneous companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Profitability

This table compares OWC Pharmaceutical Research and GrowGeneration's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
OWC Pharmaceutical ResearchN/AN/AN/A
GrowGeneration2.14%4.68%3.53%

Insider & Institutional Ownership

51.3% of GrowGeneration shares are owned by institutional investors. 13.6% of GrowGeneration shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for OWC Pharmaceutical Research and GrowGeneration, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
OWC Pharmaceutical Research0000N/A
GrowGeneration03502.63

GrowGeneration has a consensus price target of $49.5714, suggesting a potential downside of 8.24%. Given GrowGeneration's higher probable upside, analysts clearly believe GrowGeneration is more favorable than OWC Pharmaceutical Research.

Valuation & Earnings

This table compares OWC Pharmaceutical Research and GrowGeneration's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OWC Pharmaceutical ResearchN/AN/AN/AN/AN/A
GrowGeneration$79 million39.97$1.88 million$0.10540.20

GrowGeneration has higher revenue and earnings than OWC Pharmaceutical Research.

Summary

GrowGeneration beats OWC Pharmaceutical Research on 8 of the 8 factors compared between the two stocks.

OWC Pharmaceutical Research (OTCMKTS:OWCP) and 22nd Century Group (NYSEAMERICAN:XXII) are both miscellaneous companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Profitability

This table compares OWC Pharmaceutical Research and 22nd Century Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
OWC Pharmaceutical ResearchN/AN/AN/A
22nd Century GroupN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for OWC Pharmaceutical Research and 22nd Century Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
OWC Pharmaceutical Research0000N/A
22nd Century Group00103.00

Valuation & Earnings

This table compares OWC Pharmaceutical Research and 22nd Century Group's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OWC Pharmaceutical ResearchN/AN/AN/AN/AN/A
22nd Century GroupN/AN/AN/AN/AN/A

Summary

22nd Century Group beats OWC Pharmaceutical Research on 1 of the 1 factors compared between the two stocks.

OWC Pharmaceutical Research (OTCMKTS:OWCP) and KushCo (OTCMKTS:KSHB) are both miscellaneous companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for OWC Pharmaceutical Research and KushCo, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
OWC Pharmaceutical Research0000N/A
KushCo01302.75

KushCo has a consensus price target of $1.8750, suggesting a potential upside of 45.35%. Given KushCo's higher probable upside, analysts clearly believe KushCo is more favorable than OWC Pharmaceutical Research.

Valuation & Earnings

This table compares OWC Pharmaceutical Research and KushCo's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OWC Pharmaceutical ResearchN/AN/AN/AN/AN/A
KushCo$113.84 million1.80$-77,660,000.00($0.68)-1.90

OWC Pharmaceutical Research has higher earnings, but lower revenue than KushCo.

Insider & Institutional Ownership

0.0% of KushCo shares are owned by institutional investors. 17.3% of KushCo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares OWC Pharmaceutical Research and KushCo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
OWC Pharmaceutical ResearchN/AN/AN/A
KushCo-65.89%-47.95%-31.39%

Summary

KushCo beats OWC Pharmaceutical Research on 5 of the 8 factors compared between the two stocks.

NSAV (OTCMKTS:NSAV) and OWC Pharmaceutical Research (OTCMKTS:OWCP) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.

Analyst Recommendations

This is a summary of recent ratings for NSAV and OWC Pharmaceutical Research, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
NSAV0000N/A
OWC Pharmaceutical Research0000N/A

Earnings & Valuation

This table compares NSAV and OWC Pharmaceutical Research's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NSAVN/AN/AN/AN/AN/A
OWC Pharmaceutical ResearchN/AN/AN/AN/AN/A

Profitability

This table compares NSAV and OWC Pharmaceutical Research's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NSAVN/AN/AN/A
OWC Pharmaceutical ResearchN/AN/AN/A

Terra Tech (OTCMKTS:TRTC) and OWC Pharmaceutical Research (OTCMKTS:OWCP) are both industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.

Analyst Recommendations

This is a summary of recent ratings for Terra Tech and OWC Pharmaceutical Research, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Terra Tech0000N/A
OWC Pharmaceutical Research0000N/A

Earnings & Valuation

This table compares Terra Tech and OWC Pharmaceutical Research's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Terra Tech$28.05 million2.25$-46,930,000.00N/AN/A
OWC Pharmaceutical ResearchN/AN/AN/AN/AN/A

OWC Pharmaceutical Research has lower revenue, but higher earnings than Terra Tech.

Insider & Institutional Ownership

0.1% of Terra Tech shares are owned by institutional investors. 6.7% of Terra Tech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Terra Tech and OWC Pharmaceutical Research's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Terra Tech-261.88%-110.38%-62.41%
OWC Pharmaceutical ResearchN/AN/AN/A


OWC Pharmaceutical Research Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Innovative Industrial Properties logo
IIPR
Innovative Industrial Properties
1.8$188.99-2.5%$4.52 billion$44.67 million61.16
GrowGeneration logo
GRWG
GrowGeneration
1.7$54.02-2.3%$3.16 billion$79 million1,080.62Analyst Revision
22nd Century Group logo
XXII
22nd Century Group
0.9$3.61-2.5%$550.16 millionN/A0.00
KushCo logo
KSHB
KushCo
1.3$1.29-3.1%$204.89 million$113.84 million-2.15Earnings Announcement
News Coverage
Gap Up
NSAV
NSAV
0.3$0.02-0.0%$129.95 millionN/A0.00News Coverage
Gap Down
Terra Tech logo
TRTC
Terra Tech
0.7$0.29-0.0%$63.02 million$28.05 million0.00News Coverage
General Cannabis logo
CANN
General Cannabis
0.6$0.89-0.0%$55.31 million$3.67 million0.00
PVSP
Pervasip
0.4$0.01-0.0%$45.10 millionN/A0.00Gap Up
Grow Capital logo
GRWC
Grow Capital
0.6$1.13-2.7%$28.07 million$2.37 million0.00News Coverage
Gap Up
NMUS
Nemus Bioscience
0.6$0.12-0.0%$16.07 millionN/A0.00High Trading Volume
Leafbuyer Technologies logo
LBUY
Leafbuyer Technologies
0.5$0.16-0.0%$13.70 million$2.53 million0.00Gap Down
MassRoots logo
MSRT
MassRoots
0.6$0.02-0.0%$11.16 million$20,000.000.00Gap Up
Peak Pharmaceuticals logo
PKPH
Peak Pharmaceuticals
0.7$0.14-0.0%$10.59 millionN/A0.00News Coverage
Mentor Capital logo
MNTR
Mentor Capital
0.5$0.16-5.1%$3.83 million$4.33 million-3.99
FutureWorld logo
FWDG
FutureWorld
0.5$0.00-0.0%$3.80 millionN/A0.00Gap Up
DIGP
DigiPath
0.5$0.05-0.2%$3.35 million$2.55 million-1.66Gap Up
NGBL
Notis Global
0.5$0.00-0.0%$2.50 millionN/A0.00Gap Up
United Cannabis logo
CNAB
United Cannabis
0.4$0.02-0.0%$1.70 millionN/A0.00
CrowdGather logo
CRWG
CrowdGather
0.7$0.01-0.0%$1.68 million$160,000.000.00News Coverage
Gap Up
OPMZ
1PM Industries
0.4$0.00-0.0%$0.00N/A0.00
AQSP
Acquired Sales
0.4$7.70-0.0%$0.00N/A0.00
AMMJ
American Cannabis
0.5$0.23-4.4%$0.00N/A0.00Gap Up
AmeriCann logo
ACAN
AmeriCann
0.4$1.21-5.0%$0.00N/A0.00Gap Down
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.25-12.0%$0.00N/A0.00
Cannabis Sativa logo
CBDS
Cannabis Sativa
0.5$0.78-6.4%$0.00N/A0.00Gap Up
FRLF
Freedom Leaf
0.5$0.01-0.0%$0.00N/A0.00Gap Up
FUTL
FutureLand
0.4$0.00-0.0%$0.00N/A0.00News Coverage
Gap Up
GB Sciences logo
GBLX
GB Sciences
0.5$0.06-0.0%$0.00N/A0.00News Coverage
Gap Down
GreenGro Technologies logo
GRNH
GreenGro Technologies
0.6$0.02-0.0%$0.00N/A0.00Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$3.06-2.0%$0.00N/A0.00
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-0.0%$0.00N/A0.00News Coverage
Gap Down
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.06-0.0%$0.00N/A0.00Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00-0.0%$0.00N/A0.00Gap Up
MDCL
Medicine Man Technologies
0.5$2.22-1.4%$0.00N/A0.00
NCAP
Northsight Capital
0.5$0.00-0.0%$0.00N/A0.00
Surna logo
SRNA
Surna
0.6$0.07-2.0%$0.00N/A0.00
Ultrack Systems logo
MJLB
Ultrack Systems
0.6$0.09-10.7%$0.00N/A0.00Gap Down
BUDZ
WEED
0.6$0.59-0.0%$0.00N/A0.00Gap Up
Zoned Properties logo
ZDPY
Zoned Properties
0.6$0.65-6.2%$0.00N/A0.00Gap Up
ZZLL
ZZLL Information Technology
0.4$0.32-57.2%$0.00N/A0.00High Trading Volume
Gap Down
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.